A Phase 1/2a, Open-label, Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BMS-986507 (BL-B01D1) Combinations in Adult Participants With Advanced Solid Tumors
A Phase 1/2a, Open-label, Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BMS-986507 (BL-B01D1) Combinations in Adult Participants With Advanced Solid Tumors
The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary efficacy of BMS-986507 combinations in adult participants with advanced solid tumors.
Inclusion Criteria
Exclusion Criteria
Clinical.Trials@bms.com855-907-3286
Birmingham, Alabama 35294, United States
919-525-0054
Miami, Florida 33136, United States
Hackensack, New Jersey 07601, United States
Bordeaux, Aquitaine 33076, France
Marseille, Bouches-du-RhĂ´ne 13385, France
Candiolo, Torino 10060, Italy
Roma, 00168, Italy
Amsterdam, 1066 CX, Netherlands
Santiago de Compostela, A Coruña [La Coruña] 15706, Spain
Hospitalet, Barcelona [Barcelona] 08907, Spain
34932275402
Majadahonda, Madrid, Comunidad de 28222, Spain
Birmingham, West Midlands B15 2GW, United Kingdom
305-243-1086
551-996-5863
734-615-2939
503-215-5401
503-215-5401
865-305-8780
210-580-9500
206-386-2457
61287389744
+61731766577
+61402147682
7804328248
6137377700
5148908000
514340822224915
+56992195434
+56998744662
33556333229
+33469856041
33491324400
+33467330759
33142114211
+33624456290
33156016531
390434659294
390223903829
390119933250
00390557947298
+390630153446
31715262950
0031205122958
34932746077
0034913908922
34911917759
349155048002805
00349422033350000
34961245877
442077040500
441214158237